The Imaging and Bioengineering theme’s research focuses on helping clinical translation of core science and technologies in molecular imaging and image acquisition, analysis and computational modelling.

The theme integrates the research activities of the Kings College London (KCL) Imaging Sciences and Biomedical Engineering Division and the clinical units of the GSTT and KCH Trusts which form the Imaging and Biomedical Engineering Clinical Academic Group (CAG) at King’s Health Partners (KHP).

Areas of focus

Cluster One – Experimental Medicine and Therapeutics:

  • To move new PET, SPECT and MR molecular imaging and radionuclide therapy agents into man

Cluster Two – Biomarkers, Co-Diagnostics, Imaging and Devices Cluster:

  • To implement new core imaging software platforms across the 3 London BRCs, enabling the sharing of innovations in acquisition, processing and modelling software for clinical research
  • To use new image guided techniques for improving the outcomes of interventions in congenital heart disease, cardiac arrhythmias and heart failure (cardiac resynchronisation therapy)
  • To translate new multimodality cancer imaging methods into improved patient care
  • To reduce neuro-disability by using new MRI imaging biomarkers to assess novel therapies


  • Development of a tool for in vivo cardiac diffusion tensor imaging to (i) provide a dedicated analysis technique for the ventricle shape and (ii) describe fibre orientation of the full ventricle
  • Development of a biomedical visualiser. The project aims to create a software platform for the visualization of 3D mathematical models of physiology, computational simulation data, and imaging data
  • Tools for quantification of myocardial properties

External links